|
Hayakawa, Jun; Mittal, Shalu; Wang, Yipeng et al. (2004) Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol Cell 16:521-35
|
|
Hayakawa, Jun; Depatie, Chantal; Ohmichi, Masahide et al. (2003) The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. J Biol Chem 278:20582-92
|
|
Yang, Yong-Min; Bost, Frederic; Charbono, Wilfried et al. (2003) C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. Clin Cancer Res 9:391-401
|
|
Cripe, L D; Gelfanov, V M; Smith, E A et al. (2002) Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation. Leukemia 16:799-812
|
|
Gjerset, R; Haghighi, A; Lebedeva, S et al. (2001) Gene therapy approaches to sensitization of human prostate carcinoma to cisplatin by adenoviral expression of p53 and by antisense jun kinase oligonucleotide methods. Methods Mol Biol 175:495-520
|
|
Potapova, O; Gorospe, M; Bost, F et al. (2000) c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J Biol Chem 275:24767-75
|
|
de Belle, I; Mercola, D; Adamson, E D (2000) Method for cloning in vivo targets of the Egr-1 transcription factor. Biotechniques 29:162-9
|
|
Liu, C; Yao, J; Mercola, D et al. (2000) The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251. J Biol Chem 275:20315-23
|
|
Hayakawa, J; Ohmichi, M; Kurachi, H et al. (1999) Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J Biol Chem 274:31648-54
|
|
Liu, C; Yao, J; de Belle, I et al. (1999) The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1. J Biol Chem 274:4400-11
|
Showing the most recent 10 out of 22 publications
